| Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: a single center study of 100 patients in Brescia, Italy P Toniati, S Piva, M Cattalini, E Garrafa, F Regola, F Castelli, ... Autoimmunity reviews 19 (7), 102568, 2020 | 697 | 2020 |
| EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and … L Andreoli, GK Bertsias, N Agmon-Levin, S Brown, R Cervera, ... Annals of the rheumatic diseases 76 (3), 476-485, 2017 | 573 | 2017 |
| EULAR recommendations for the management of antiphospholipid syndrome in adults MG Tektonidou, L Andreoli, M Limper, Z Amoura, R Cervera, ... Annals of the rheumatic diseases 78 (10), 1296-1304, 2019 | 493 | 2019 |
| Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome V Pengo, G Denas, G Zoppellaro, SP Jose, A Hoxha, A Ruffatti, L Andreoli, ... Blood, The Journal of the American Society of Hematology 132 (13), 1365-1371, 2018 | 467 | 2018 |
| Covid-19 and autoimmunity M Ehrenfeld, A Tincani, L Andreoli, M Cattalini, A Greenbaum, D Kanduc, ... Autoimmunity reviews 19 (8), 102597, 2020 | 291 | 2020 |
| Estimated frequency of antiphospholipid antibodies in patients with pregnancy morbidity, stroke, myocardial infarction, and deep vein thrombosis: a critical review of the … L Andreoli, CB Chighizola, A Banzato, GJ Pons‐Estel, GR de Jesus, ... Arthritis care & research 65 (11), 1869-1873, 2013 | 252 | 2013 |
| 14th International Congress on Antiphospholipid Antibodies Task Force. Report on antiphospholipid syndrome laboratory diagnostics and trends ML Bertolaccini, O Amengual, L Andreoli, T Atsumi, CB Chighizola, ... Autoimmunity reviews 13 (9), 917-930, 2014 | 236 | 2014 |
| State of the art: reproduction and pregnancy in rheumatic diseases M Østensen, L Andreoli, A Brucato, I Cetin, C Chambers, MEB Clowse, ... Autoimmunity reviews 14 (5), 376-386, 2015 | 210 | 2015 |
| Novel aspects of Sjögren’s syndrome in 2012 A Tincani, L Andreoli, I Cavazzana, A Doria, M Favero, MG Fenini, ... BMC medicine 11 (1), 1-18, 2013 | 200 | 2013 |
| 14th International Congress on Antiphospholipid Antibodies Task Force report on obstetric antiphospholipid syndrome GR de Jesus, N Agmon-Levin, CA Andrade, L Andreoli, CB Chighizola, ... Autoimmunity reviews 13 (8), 795-813, 2014 | 154 | 2014 |
| The efficacy of hydroxychloroquine for obstetrical outcome in anti-phospholipid syndrome: data from a European multicenter retrospective study A Mekinian, MG Lazzaroni, A Kuzenko, J Alijotas-Reig, A Ruffatti, P Levy, ... Autoimmunity reviews 14 (6), 498-502, 2015 | 149 | 2015 |
| Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory … M Scarsi, S Piantoni, E Colombo, P Airó, D Richini, M Miclini, V Bertasi, ... Annals of the rheumatic diseases 79 (10), 1286-1289, 2020 | 129 | 2020 |
| The antiphospholipid syndrome in patients with systemic lupus erythematosus GJ Pons-Estel, L Andreoli, F Scanzi, R Cervera, A Tincani Journal of autoimmunity 76, 10-20, 2017 | 122 | 2017 |
| The estimated frequency of antiphospholipid antibodies in young adults with cerebrovascular events: a systematic review S Sciascia, G Sanna, MA Khamashta, MJ Cuadrado, D Erkan, L Andreoli, ... Annals of the rheumatic diseases 74 (11), 2028-2033, 2015 | 116 | 2015 |
| Ramire de Jesus G, Erkan D. Estimated frequency of antiphospholipid antibodies in patients with pregnancy morbidity, stroke, myocardial infarction, and deep vein thrombosis: a … L Andreoli, CB Chighizola, A Banzato, GJ Pons-Estel Arthritis Care Res (Hoboken) 65 (11), 1869-73, 2013 | 113 | 2013 |
| Treatment strategies and pregnancy outcomes in antiphospholipid syndrome patients with thrombosis and triple antiphospholipid positivity A Ruffatti, E Salvan, T Del Ross, M Gerosa, L Andreoli, A Maina, ... Thrombosis and haemostasis 112 (10), 727-735, 2014 | 111 | 2014 |
| Pregnancy implications for systemic lupus erythematosus and the antiphospholipid syndrome L Andreoli, M Fredi, C Nalli, R Reggia, A Lojacono, M Motta, A Tincani Journal of autoimmunity 38 (2-3), J197-J208, 2012 | 110 | 2012 |
| COVID-19 in patients with rheumatic diseases in northern Italy: a single-centre observational and case–control study M Fredi, I Cavazzana, L Moschetti, L Andreoli, F Franceschini, P Airò, ... The Lancet Rheumatology 2 (9), e549-e556, 2020 | 106 | 2020 |
| Effects of belimumab on flare rate and expected damage progression in patients with active systemic lupus erythematosus L Iaccarino, S Bettio, R Reggia, M Zen, M Frassi, L Andreoli, M Gatto, ... Arthritis care & research 69 (1), 115-123, 2017 | 102 | 2017 |
| Anti-phospholipid antibodies in COVID-19 are different from those detectable in the anti-phospholipid syndrome MO Borghi, A Beltagy, E Garrafa, D Curreli, G Cecchini, C Bodio, C Grossi, ... Frontiers in immunology, 2692, 2020 | 100 | 2020 |
